Sign in

NCT05119855CompletedPhase 3

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age

Source: ClinicalTrials.gov · Last updated 5 Feb 2026

Brief summary (registry, in English)

The purpose of this study to evaluate the safety and immunogenicity of a 2-dose regimen of 9vHPV vaccine, where the first dose is administered concomitantly with a first dose of a 2-dose regimen of mRNA-1273 vaccine versus nonconcomitant administration of 9vHPV and mRNA-1273 vaccines in boys and girls 9 to 11 years of age.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
165 (actual)
First submitted
10 Nov 2021
Start date
28 Mar 2022
Primary completion date
12 Dec 2023
Lead sponsor
Merck Sharp & Dohme LLC
NCT number
NCT05119855
EudraCT number
2021-003591-13

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 165
  • From 28 Mar 2022 to the primary completion date, 12 Dec 2023
  • 38 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Has a history of a clinical or microbiological diagnosis of COVID-19 ≤90 days prior to Day 1 visit or history of multisystem inflammatory syndrome in children (MIS-C) at any time prior to Day 1 visit
  • Receiving or has received immunosuppressive therapies within the last year
  • Received any immunoglobulin product or blood-derived product within 3 months
  • Received a marketed HPV vaccine or has participated in an HPV vaccine clinical trial

Other illness

  • Known allergy to any vaccine component
  • History of severe allergic reaction that required medical intervention
  • Thrombocytopenia or any coagulation disorder
  • Has a history of myocarditis or pericarditis

Other

  • Females only: participant is pregnant
  • Currently immunocompromised, or been diagnosed with immunodeficiency
  • Had a splenectomy

Who the study is looking for

  • Has not yet had coitarche and does not plan on becoming sexually active during the vaccination period
  • Participant or participant's legally acceptable representative can read, understand, and complete the electronic vaccination report card (eVRC).

Age in the registry: 9 years to 11 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (38)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Atlanta Center for Medical Research ( Site 0055)
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
DermResearch, Inc. ( Site 0056)
Coordinator of this site? Confirm its status
AustinUnited StatesUnknown status
Coast Clinical Research, LLC ( Site 0027)
Coordinator of this site? Confirm its status
BellflowerUnited StatesUnknown status
WR-ClinSearch ( Site 0049)
Coordinator of this site? Confirm its status
ChattanoogaUnited StatesUnknown status
South Texas Clinical Research ( Site 0024)
Coordinator of this site? Confirm its status
Corpus ChristiUnited StatesUnknown status
Certified Research Associates ( Site 0090)
Coordinator of this site? Confirm its status
CortlandUnited StatesUnknown status
Dayton Clinical Research ( Site 0028)
Coordinator of this site? Confirm its status
DaytonUnited StatesUnknown status
Accel Research Sites-DeLand Clinical Research Unit ( Site 0066)
Coordinator of this site? Confirm its status
DeLandUnited StatesUnknown status
South Texas Pediatric Research Group ( Site 0094)
Coordinator of this site? Confirm its status
Del RioUnited StatesUnknown status
Carolina Institute for Clinical Research, LLC ( Site 0042)
Coordinator of this site? Confirm its status
FayettevilleUnited StatesUnknown status
CBH Health ( Site 0019)
Coordinator of this site? Confirm its status
GaithersburgUnited StatesUnknown status
Corning Center for Clinical Research ( Site 0091)
Coordinator of this site? Confirm its status
HorseheadsUnited StatesUnknown status
Next Level Urgent Care, LLC ( Site 0099)
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
West Houston Clinical Research Services ( Site 0078)
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
Clinical Research Prime ( Site 0088)
Coordinator of this site? Confirm its status
Idaho FallsUnited StatesUnknown status
Advanced Research for Health Improvement, LLC ( Site 0012)
Coordinator of this site? Confirm its status
ImmokaleeUnited StatesUnknown status
Children's Clinic of Jonesboro, PA ( Site 0044)
Coordinator of this site? Confirm its status
JonesboroUnited StatesUnknown status
Milton Haber, M.D. ( Site 0069)
Coordinator of this site? Confirm its status
LaredoUnited StatesUnknown status
University of Texas Medical Branch ( Site 0026)
Coordinator of this site? Confirm its status
League CityUnited StatesUnknown status
Midwest Children's Health Research Institute ( Site 0003)
Coordinator of this site? Confirm its status
LincolnUnited StatesUnknown status
Preferred Research Partners Inc. ( Site 0092)
Coordinator of this site? Confirm its status
Little RockUnited StatesUnknown status
Ark Clinical Research ( Site 0098)
Coordinator of this site? Confirm its status
Long BeachUnited StatesUnknown status
Alpha Science Research ( Site 0067)
Coordinator of this site? Confirm its status
MiamiUnited StatesUnknown status
Acevedo Clinical Research Associates ( Site 0001)
Coordinator of this site? Confirm its status
MiamiUnited StatesUnknown status
Advanced Research For Health Improvement LLC ( Site 0075)
Coordinator of this site? Confirm its status
NaplesUnited StatesUnknown status
Valley Clinical Trials Inc. ( Site 0004)
Coordinator of this site? Confirm its status
NorthridgeUnited StatesUnknown status
Thomas Jefferson University - Family and Community Medicine ( Site 0006)
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Cognitive Clinical Trials, LLC ( Site 0054)
Coordinator of this site? Confirm its status
PhoenixUnited StatesUnknown status
M3 Wake Research, Inc. ( Site 0014)
Coordinator of this site? Confirm its status
RaleighUnited StatesUnknown status
SKY Integrative Medical Center/SKYCRNG ( Site 0084)
Coordinator of this site? Confirm its status
RidgelandUnited StatesUnknown status
University of Utah ( Site 0076)
Coordinator of this site? Confirm its status
Salt Lake CityUnited StatesUnknown status
Medical Center for Clinical Research ( Site 0051)
Coordinator of this site? Confirm its status
San DiegoUnited StatesUnknown status
Mount Vernon Clinical Research ( Site 0053)
Coordinator of this site? Confirm its status
Sandy SpringsUnited StatesUnknown status
Eclipse Clinical Research ( Site 0095)
Coordinator of this site? Confirm its status
TucsonUnited StatesUnknown status
Ark Clinical Research ( Site 0108)
Coordinator of this site? Confirm its status
TustinUnited StatesUnknown status
Emerson Clinical Research Institute ( Site 0021)
Coordinator of this site? Confirm its status
Washington D.C.United StatesUnknown status
Velocity Clinical Research, Salt Lake City ( Site 0025)
Coordinator of this site? Confirm its status
West JordanUnited StatesUnknown status
Comprehensive Clinical Research ( Site 0038)
Coordinator of this site? Confirm its status
West Palm BeachUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.